CRISPR THERAPEUTICS AG COM CHF0.03CRISPR THERAPEUTICS AG COM CHF0.03CRISPR THERAPEUTICS AG COM CHF0.03

CRISPR THERAPEUTICS AG COM CHF0.03

No trades
See on Supercharts

Price target

81.280.000.00%
The 25 analysts offering 1 year price forecasts for 0VRQ have a max estimate of — and a min estimate of —.

Analyst rating

Based on 31 analysts giving stock ratings to 0VRQ in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


0VRQ EPS for the last quarter is −1.49 USD despite the estimation of −1.43 USD. In the next quarter EPS is expected to reach −1.42 USD. Track more of CRISPR THERAPEUTICS AG COM CHF0.03 financials and stay on top of what is up with the company.
In the next quarter CRISPR THERAPEUTICS AG COM CHF0.03 revenue is expected to reach ‪6.65 M‬ USD. Check out CRISPR THERAPEUTICS AG COM CHF0.03 revenue and earnings and make informed decisions.
According to analysts, 0VRQ price target is 81.28 USD with a max estimate of 199.00 USD and a min estimate of 30.00 USD. Check if this forecast comes true in a year, meanwhile watch CRISPR THERAPEUTICS AG COM CHF0.03 stock price chart and keep track of the current situation with 0VRQ news and stock market news.
We've gathered opinions of 31 analysts rating 0VRQ stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.